1971: MD, Faculté de Médecine et de Pharmacie de Toulouse, Université Paul Sabatier, France
1971-1973: Interne des Hôpitaux de Toulouse, Centre Hospitalo-Universitaire de Toulouse, France
1973-1974: Residency, Surgery, Hadassah Hebrew University Hospital, Jerusalem, Israel
1974-1978: Residency, ENT, Hadassah Hebrew University Hospital, Jerusalem, Israel
January 1979: Boards (Israeli Medical Association), ENT, Hadassah Hebrew University Hospital, Jerusalem, Israel
1982-1985: Residency, Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
October 1985: Boards (Israeli Medical Association), Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
August 1986-August 1988: NMR Research Fellow, MRI, MGH, Department of Radiology, Boston, MA, USA
February 1990-Dec. 1996: Acting Head, Dept. of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
January 1997-present: Head of Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel
July 1993-February 1994: Special Volunteer, PET, NIH, Department of PET and Nuclear Medicine, Bethesda, Maryland, USA
August-October 1999: Visiting Professor, PET, Memorial Sloane-Kettering Cancer Center, Nuclear Medicine Service, New York, NY, USA
July 1993-Present: Associate Professor of Nuclear Medicine and Medical Biophysics, HU, Jerusalem, Israel
October 1982 - present: Senior Otorhinolaryngologist, ENT Department, Hadassah HU Hospital, Jerusalem (1/8 time activity), Israel
November 2007 - Full Professor of Nuclear Medicine and Medical Biophysics, HU, Jerusalem, Israel
Immediate Past President of the Israeli Society of Nuclear Medicine (July 1999-July 2002).
1. Freedman, N.M.TPI., Mishani, EC., Krausz, YC., Weininger, JT., Lester, HT., Blaugrund, EC., Ehrlich, DC., Chisin, RPI. 2005. In-Vivo Measurement of Brain Monoamine Oxidase B Occupancy by Rasagiline, using 11C-L-Deprenyl and PET. J.Nucl. Med. , 46:1618-1624. (4.684;3/84;0)
2. Shamai-Tsoory, GPI., Lester, HT., Chisin, RC., Israel, OC., Bar-Shalom, RC., Tomer, RC., Tsitrinbaum, ZC., Aharon-Peretz, JPI. 2005. The neural correlates of understanding the other's distress: A Positron Emission Tomography Investigation of accurate empathy. Neuroimage, 27:468-472. (5.288;21/200,1/14,2/84;1;1)
3. Jacobson, OS., Bechor, YS., Icar, AS., Novak, NS., Birman, AS., Marom, HS., Fadeeva, LS., Golan, ES., Leibovitch, IC., Gutman, MC., Even-Sapir, EC., Chisin, RC., Gozin, MC., Mishani, EPI. 2005. Prostate cancer PET bioprobes: a synthesis of [18F]-radiolabeled hydroxyflutamide derivatives. Bioorg. Med. Chem., 13(22):6195-6205. (2.286;135/261,10/34.22/55;5;4)
4. Krausz, YPI., Bettman, LC., Guralnik, LC., Yosilevsky, GT., Keidar, ZC., Bar-Shalom, RC., Even-Sapir, EC., Chisin, RC., Israel, OPI. 2006. Tc99m-MIBI SPECT/CT in Primary Hyperparathyroidism. World J. Surg., 30(1):76-83. (1.601;46/139;2;2)
5. Krausz, YPI., Freedman, NC., Lester, HT., Barkai, GC., Levin, TC., Bocher, MC., Chisin, RC., Lerer, BC., Bonne, OPI. 2006. Brain SPECT study of common ground between hypothyroidism and depression. J. Neuropsychopharmacol., 4:1-8. (5.184;11/147, 27/200, 20/199, 8/94 0)
6. Gofrit, NPI., Mishani, EC., Orevi, MC., Klein, MC., Freedman, NC., Pode, DC., Shapiro, AC., Katz, RC., Libson, EC., Chisin, RPI. 2006. Contribution of 11C-Choline PET/CT to preoperative staging of patients with advanced transitional cell carcinoma. J. of Urology, 176:940-944. (3.956, 8/55 7;7)
7. Jacobson, OPI., Laky, DT., Carlson, K.EC., Elgavish, SC., Gozin, MC., Even-Sapir, EC., Leibovitch, IC., Gutman, MC., Chisin, RC., Katzenellenbogen, J.AC., Mishani, EPI. 2006. Chiral dimethylamine flutamide derivatives – modeling, synthesis, androgen receptor affinities, and carbon-11 labeling. Nucl. Med. Biol., 33:695-704. (2.121, 30/85 3;3)
8. Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Freedman, N., Mechoulam, R., Bar-Hamburger, R., Chisin, R., Even-Sapir, E. 2006. Brain imaging study of the acute effects of Δ-9 THC on attention and motor coordination in regular users of marijuana. Psychopharmacology, 196(1): 119-131. Impact factor 3.625
9. Ben-Shahar, DPI., Bonne, OC., Chisin, RC., Klein, EC., Lester, HT., Aharon-Peretz, JC., Yona, IC., Freedman, NPI. 2007. Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study. Accepted for publication in Progress in Neuro-Psychopharmacology & Biological Psychiatry. (31(4);807-13 (2.584, 45/147 97/200 68/199 35/94 1;1)
10. Kohn, Y., Freedman, N., Lester, H., Krausz, Y., Chisin, R., Lerer, B., Bonne, O. 2007. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. J. Nucl. Med., 48;1273-8. (4.986, 4/85 1;1)
11. Rozovsky, KPI., Koplewitz, BC., Krausz, YC., Revel-Vilk, SC., Weintraub, MC., Chisin, RPI., Klein, MPI. 2008. The added value of SPECT/CT for the correlation of MIBG scan and diagnostic CT in neuroblastoma and pheochromocytoma. Am J Roentgenol 190:1085-1090.(2.117, 31/85 0).
12. Bar-Haim, E., Katz, N., Chisin, R., Abramsky, O., Mishani, E., Freedman, N. 2008. Neural mechanism of visual attention in unilateral spatial negleet following stroke: A preliminary PET Study. The Israeli Journal of Occupational Therapy, 17:3-22.
13. Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Chisin, R., Sarne, Y., Mechoulam, R., Bar-Hamburger, R., Freedman, N., Even-Sapir, E. 2008. A study investigating the acute dose-response effects of 13 mg and 17 mg Δ 9-THC on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. Journal of Psychopharmacology, 22:441-51.
14. Ilovich, O., Jacobson, O., Aviv, Y., Litchi, A., Chisin, R., Mishani, E. 2008. Formation of fluorine-18 labeled diaryl ureas-labeled VEGFR-2/PDGFR dual inhibitors as molecular imaging agents for angiogenesis. Bioorg Med Chem, 16(8):4242-51.
15. Kohn Y., Freedman N., Lester H., Krausz Y., Chisin R., Lerer B., Bonne O. 2008. Cerebral perfusion after a two year remission in major depression. Int J Neuropsychopharmacol. 11:837-843.
16. Chisin, R. 2009. Cost-Effectiveness Analysis (Invited perspective) J.Nucl.Med.50:338-339.
17. Krausz Y, Freedman N, Rubinstein R, Lavie E, Orevi M, Tshori S, Salmon A, Glaser B, Chisin R, Mishani E, Gross D. 2010. 68 Ga-DOTA-NOC PET/CT imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (Octreoscan). Accepted for publication in Molecular Imaging & Biology. 2010.